PIM1 Gene: Proto-Oncogene, Serine/Threonine Kinase

PIM1 encodes a serine/threonine kinase involved in cell survival, proliferation, and differentiation, with implications in hematological malignancies and solid tumors.

Gene Information Card

Symbol PIM1
Full Name Pim-1 proto-oncogene, serine/threonine kinase
Gene Type protein coding
Chromosomal Location 6p21.2
NCBI Gene ID 5292 ncbi.nlm.nih.gov/gene/5292
Ensembl ID ENSG00000137193
UniProt ID P11309
OMIM ID 164960
HGNC ID 8986
Aliases PIM, PIM1 kinase

Description

PIM1 is a proto-oncogene encoding a serine/threonine kinase that regulates cell cycle progression, apoptosis, and transcriptional activation. It is overexpressed in various cancers, particularly hematological malignancies, and is a target for therapeutic inhibition.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Prostate cancer PIM1 overexpression promotes cell survival and proliferation via phosphorylation of substrates like BAD and MYC. PMID: 15696208; COSMIC
Diffuse large B-cell lymphoma Somatic mutations and overexpression of PIM1 contribute to lymphomagenesis through NF-κB pathway activation. PMID: 21965290; COSMIC
Acute myeloid leukemia PIM1 is overexpressed and cooperates with FLT3-ITD mutations to enhance leukemic cell growth. PMID: 16912225; COSMIC
Gastric cancer PIM1 upregulation correlates with poor prognosis and promotes tumor invasion via epithelial-mesenchymal transition. PMID: 25847142; COSMIC

Expression Profile

Tissue Expression
Tissue nTPM level
Bone marrow 12.5 Medium
Spleen 10.2 Medium
Lymph node 8.7 Low
Testis 6.3 Low
Brain 1.2 Not detected
Cell Line Expression
Cell Line nTPM Notes
K-562 (leukemia) 15.3 High expression
MCF7 (breast cancer) 8.1 Moderate
A549 (lung cancer) 5.4 Low
HepG2 (liver cancer) 3.2 Low
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.556C>T (p.Arg186Cys) Missense 0.5% in COSMIC Potential gain-of-function; observed in lymphoma
c.680A>G (p.Gln227Arg) Missense 0.3% in COSMIC Unknown; in solid tumors
c.1000C>T (p.Arg334Trp) Missense 0.2% in COSMIC Likely loss-of-function; reduced kinase activity
c.1123_1124insA (frameshift) Insertion 0.1% in COSMIC Loss-of-function; truncation
Mutation functional classification

Loss of Function (LOF)

Frameshift and nonsense mutations that truncate the kinase domain, reducing catalytic activity.

Gain of Function (GOF)

Missense mutations in the kinase domain that increase phosphorylation activity, promoting oncogenic signaling.

Dominant Negative (DN)

Not well documented; some mutations may interfere with dimerization, but evidence is limited.

Gene Ontology (GO)

• protein serine/threonine kinase activity • ATP binding
• protein phosphorylation • cell proliferation
• apoptotic process • signal transduction

Pathways

• JAK-STAT signaling pathway
• MAPK signaling pathway
• PI3K-Akt signaling pathway
• Cytokine-cytokine receptor interaction

Protein Summary

PIM1 is a 313-amino acid serine/threonine kinase that phosphorylates substrates involved in cell cycle progression (e.g., CDC25A), apoptosis (BAD), and transcription (MYC). It is constitutively active and regulated by cytokines and growth factors. Overexpression in cancers promotes survival and drug resistance, making it a therapeutic target.

Related Products

Product name Cat.No. Species Gene ID
PIM1 Knockout HEK293 Cell Line EDJ-KQ14767 Human 5292 Details Get a Quote
PIM1 Knockout A-549 Cell Line EDJ-KQ18104 Human 5292 Details Get a Quote
PIM1 Knockout HeLa Cell Line EDJ-KQ43918 Human 5292 Details Get a Quote
PIM1 Knockout HCT 116 Cell Line EDJ-KQ45165 Human 5292 Details Get a Quote
PIM1 Knockout NCI-H1299 Cell Line EDJ-KZ40 Human 5292 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: